23 Feb Precision BioSciences
Cindy Atwell, Senior Vice President, Business Development
Oct. 11 | 5:15pm | UBC Ballroom
Precision BioSciences is a clinical-stage biotechnology company dedicated to improving life with its novel and proprietary ARCUS® genome editing platform. ARCUS is a highly specific and versatile genome editing platform designed with therapeutic safety, delivery, and control in mind. Using ARCUS, Precision is developing allogeneic CAR T and in vivo gene correction therapies for cancer, rare diseases, and infectious diseases.